Jana Adámková

Multiple sclerosis, neuromyelitis optica spectrum disorder and COVID-19: A pandemic year in Czechia

Dominika Šťastná, Ingrid Menkyová, Jiří Drahota et al. · Multiple Sclerosis and Related Disorders · 2021 · 31 citations · Full text

Medicine, Infectious Diseases, Neurology +8

Does initial high efficacy therapy in multiple sclerosis surpass escalation treatment strategy? A comparison of patients with relapsing-remitting multiple sclerosis in the Czech and Swedish national multiple sclerosis registries

Tereza Hrnčiarová, Jiří Drahota, Tim Spelman et al. · Multiple Sclerosis and Related Disorders · 2023 · 19 citations

Pharmacy, Neurology, Pharmacotherapy +10

The Czech National MS Registry (ReMuS): Data trends in multiple sclerosis patients whose first disease-modifying therapies were initiated from 2013 to 2021

Dominika Šťastná, Jiří Drahota, Michal Lauer et al. · Biomedical Papers · 2023 · 17 citations · Full text

Medicine, Neurology, Pharmacotherapy +10

Is pregnancy in MS patients safe and what is its impact on MS course? Real World evidence of 1533 pregnancies in Czech Republic

Pavel Hradílek, Eva Meluzínová, Olga Zapletalová et al. · Multiple Sclerosis and Related Disorders · 2021 · 12 citations

Medicine, Maternal Health, Obstetrics +15

Initiation of first disease-modifying treatment for multiple sclerosis patients in the Czech republic from 2013 to 2016: Data from the national registry ReMuS

Dana Horáková, Petra Ročková, Jitka Jirčíková et al. · Multiple Sclerosis and Related Disorders · 2019 · 11 citations

Medicine, Neurology, Neuroimmunology +7